Evaluating the effectiveness of an antimicrobial stewardship program on reducing the incidence rate of healthcare-associated clostridium difficile infection: A Non-randomized, stepped wedge, single-site, observational study

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  DiDiodato, Giulio ^a   McArthur, Leslie ^a  

^a Royal Victoria Hospital Barrie   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; CANADA; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDICAL AUDIT; MEDICINE WARD; MIDDLE AGED; NONHUMAN; OBSERVATIONAL STUDY; PATIENT SAFETY; PROGRAM EFFECTIVENESS; RISK REDUCTION; SURGICAL WARD; TREATMENT DURATION; TREND STUDY; WARD; CLINICAL AUDIT; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEALTH CARE FACILITY; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; ORGANIZATION AND MANAGEMENT; PEPTOCLOSTRIDIUM DIFFICILE; REGRESSION ANALYSIS; RISK FACTOR; RISK MANAGEMENT;

AGED; ANTI-BACTERIAL AGENTS; CANADA; CEPHALOSPORINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; FLUOROQUINOLONES; HUMANS; INJECTIONS, INTRAVENOUS; MEDICAL AUDIT; MIDDLE AGED; PATIENTS' ROOMS; REGRESSION ANALYSIS; RISK FACTORS; RISK MANAGEMENT;

EID: 84976345887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157671     Document Type: Article

References (46)

1. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015; 372: 1539-1548. doi: 10. 1056/NEJMra1403772 PMID: 25875259
2. Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ. 2012; 184: 37-42. doi: 10.1503/ cmaj.110543 PMID: 22143235
3. Levy AR, Szabo SM, Lozano-Ortega G, Lloyd-Smith E, Leung V, Lawrence R, et al. Incidence and Costs of Clostridium difficile Infections in Canada. Open Forum Infect Dis. 2015; 2: ofv076. doi: 10. 1093/ofid/ofv076 PMID: 26191534
4. Public Health Agency of Canada. Clostridium difficile Infection: Infection Prevention and Control Guidance for Management in Acute Care Settings. 2013-01-11.
5. Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P. Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect. 2008; 70: 15-20.
6. Health Quality Ontario. Public Reporting. 2015.
7. Gerding DN, Lessa FC. The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect Dis Clin North Am. 2015; 29: 37-50. doi: 10.1016/j.idc.2014.11.004 PMID: 25582647
8. Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA. The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2015; 36: 681-687. doi: 10. 1017/ice.2015.43 PMID: 25783204
9. Tartof SY, Rieg GK, Wei R, Tseng HF, Jacobsen SJ, Yu KC. A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure. Infect Control Hosp Epidemiol. 2015: 1-8.
10. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital Ward Antibiotic Prescribing and the Risks of Clostridium difficile Infection. JAMA Intern Med. 2015.
11. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis. 2011; 53: 1100-1110. doi: 10.1093/ cid/cir672 PMID: 21998281
12. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012; 33: 322-327. doi: 10.1086/665010 PMID: 22418625
13. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013; 4: CD003543. doi: 10.1002/14651858.CD003543.pub3 PMID: 23633313
14. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014; 69: 1748-1754. doi: 10.1093/jac/dku046 PMID: 24633207
15. Becerra MB, Becerra BJ, Banta JE, Safdar N. Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis. 2015; 15: 254-015-0925-9.
16. Biswas JS, Patel A, Otter JA, van Kleef E, Goldenberg SD. Contamination of the Hospital Environment From Potential Clostridium difficile Excretors Without Active Infection. Infect Control Hosp Epidemiol. 2015; 36: 975-977. doi: 10.1017/ice.2015.79 PMID: 25857829
17. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O'Connor L, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013; 369: 1195-1205. doi: 10.1056/ NEJMoa1216064 PMID: 24066741
18. Cooke J, Stephens P, Ashiru-Oredope D, Johnson AP, Livermore DM, Sharland M, et al. Antibacterial usage in English NHS hospitals as part of a national Antimicrobial Stewardship Programme. Public Health. 2014; 128: 693-697. doi: 10.1016/j.puhe.2014.06.023 PMID: 25132393
19. Palmay L, Elligsen M, Walker SA, Pinto R, Walker S, Einarson T, et al. Hospital-wide Roll-out of Antimicrobial Stewardship: A Stepped-Wedge Randomized Trial. Clin Infect Dis. 2014.
20. Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J Hosp Infect. 2015; 91: 74-80. doi: 10.1016/j.jhin.2015.05.013 PMID: 26169793
21. Pakyz AL, Moczygemba LR, Wang H, Stevens MP, Edmond MB. An evaluation of the association between an antimicrobial stewardship score and antimicrobial usage. J Antimicrob Chemother. 2015; 70: 1588-1591. doi: 10.1093/jac/dku555 PMID: 25614043
22. Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA. 2014; 312: 1438-1446. doi: 10.1001/ jama.2014.12923 PMID: 25291579
23. Fridkin S, Baggs J, Fagan R, Magill S, Pollack LA, Malpiedi P, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014; 63: 194-200. PMID: 24598596
24. Accreditation Canada. Required Organizational Practices. 2015;Version 2.
25. Mdege ND, Man MS, Taylor Nee Brown CA, Torgerson DJ. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. J Clin Epidemiol. 2011; 64: 936-948. doi: 10.1016/j.jclinepi.2010.12.003 PMID: 21411284
26. Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J, ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother. 2012; 67 Suppl 1: i51-63. PMID: 22855879
27. Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Appendix B: Provincial Case Definitions for Reportable Diseases. 2014.
28. Longtin Y.,Trottier S.,Brochu G.,Paquet-Bolduc B.,Garenc C.,Loungnarath V.,Beaulieu C.,Goulet D., Longtin J. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
29. Moehring RW, Lofgren ET, Anderson DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol. 2013; 34: 1055-1061. doi: 10.1086/673144 PMID: 24018922
30. Cook PP, Gooch M. Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital. Int J Antimicrob Agents. 2015; 45: 262-267. doi: 10.1016/j.ijantimicag.2014.11.006PMID: 25554468
31. Pakyz AL, Patterson JA, Motzkus-Feagans C, Hohmann SF, Edmond MB, Lapane KL. Performance of the present-on-admission indicator for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015; 36: 838-840. doi: 10.1017/ice.2015.63 PMID: 25792197
32. Beaulac K.,Corcione S.,Epstein L.,Davidson LE.,Doron S. Antimicrobial Stewardship in a Long-Term Acute Care Hospital Using Offsite Electronic Medical Record Audit.
33. Daneman N, Stukel TA, Ma X, Vermeulen M, Guttmann A. Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada. PLoS Med. 2012; 9: e1001268. doi: 10.1371/journal.pmed.1001268 PMID: 22815656
34. Miller AC, Polgreen LA, Cavanaugh JE, Polgreen PM. Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. Am J Infect Control. 2016.
35. Dubberke ER, Reske KA, Olsen MA, McMullen KM, Mayfield JL, McDonald LC, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med. 2007; 167: 1092-1097. PMID: 17533213
36. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007; 28: 123-130. PMID: 17265392
37. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007; 45: 1543-1549. doi: 10.1086/523582 PMID: 18190314
38. Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol. 2011; 32: 481-489. doi: 10.1086/659403 PMID: 21515979
39. Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011; 32: 201-206. doi: 10.1086/658669 PMID: 21460503
40. Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, et al. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study. JAMA Intern Med. 2016.
41. Borde JP, Litterst S, Ruhnke M, Feik R, Hubner J, deWith K, et al. Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany. Infection. 2015; 43: 45-50. doi: 10.1007/s15010-014-0693-2 PMID: 25344419
42. Ostrowsky B, Ruiz R, Brown S, Chung P, Koppelman E, van Deusen Lukas C, et al. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Infect Control Hosp Epidemiol. 2014; 35 Suppl 3: S86-95. doi: 10.1086/677828 PMID: 25222903
43. Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009; 30: 346-353. doi: 10.1086/596605 PMID: 19236282
44. Passaretti CL, Barclay P, Pronovost P, Perl TM, Maryland Health Care Commission Health Care-Associated Infection Technical Advisory Committee. Public reporting of health care-associated infections (HAIs): approach to choosing HAI measures. Infect Control Hosp Epidemiol. 2011; 32: 768-774. doi: 10.1086/660873 PMID: 21768760
45. Stone SP, Fuller C, Savage J, Cookson B, Hayward A, Cooper B, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012; 344: e3005. doi: 10.1136/bmj.e3005 PMID: 22556101
46. DiDiodato G. Has improved hand hygiene compliance reduced the risk of hospital-acquired infections among hospitalized patients in Ontario? Analysis of publicly reported patient safety data from 2008 to 2011.